ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,539,737 | -39.4% | 314,655 | -31.3% | 0.21% | -42.0% |
| Q2 2023 | $14,087,773 | +1303.5% | 458,288 | +1545.0% | 0.37% | +1217.9% |
| Q1 2023 | $1,003,760 | -45.8% | 27,859 | -40.6% | 0.03% | -47.2% |
| Q4 2022 | $1,853,172 | -77.7% | 46,892 | -78.0% | 0.05% | -86.4% |
| Q1 2022 | $8,316,000 | +1053.4% | 213,440 | +1079.6% | 0.39% | +768.9% |
| Q4 2021 | $721,000 | +90.7% | 18,095 | +96.2% | 0.04% | +40.6% |
| Q2 2021 | $378,000 | -72.7% | 9,223 | -71.0% | 0.03% | -74.8% |
| Q1 2021 | $1,386,000 | – | 31,767 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |